Global X Genomics & Biotechnology ETF (GNOM) is an ETF managed by Independent / Boutique. Its largest position is Moderna, Inc. (MRNA), representing 7.86% of fund assets.
Global X Genomics & Biotechnology ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- GNOM
- Type:
- ETF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Feb 28, 2026
- Filing Date:
- Apr 29, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
Moderna, Inc.
|
7.86% | $4,116,372.37 | 76,841 |
|
-
Praxis Precision Medicines, Inc.
|
6.23% | $3,265,464.75 | 9,697 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
5.69% | $2,980,459.89 | 47,107 |
|
-
ILLUMINA, INC.
|
5.13% | $2,685,569.58 | 19,973 |
|
-
Guardant Health, Inc.
|
4.71% | $2,465,907.90 | 26,261 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
4.32% | $2,261,073.33 | 4,551 |
|
-
BIOMARIN PHARMACEUTICAL INC
|
4.31% | $2,259,194.54 | 36,598 |
|
-
Natera, Inc.
|
3.91% | $2,047,737.72 | 9,843 |
|
-
BioNTech SE
|
3.87% | $2,024,594.41 | 18,367 |
|
-
AVIDITY BIOSCIENCES INC
|
3.75% | $1,961,928.00 | 27,249 |
|
-
QIAGEN N.V.
|
3.63% | $1,902,907.80 | 38,211 |
|
-
CRISPR Therapeutics AG
|
3.48% | $1,824,527.32 | 30,338 |
|
-
BIO-TECHNE Corp
|
3.45% | $1,805,577.00 | 30,603 |
|
-
BRISTOL MYERS SQUIBB CO
|
2.65% | $1,389,478.86 | 22,278 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
2.51% | $1,312,037.72 | 3,941 |
|
-
APPLIED MATERIALS INC /DE
|
2.39% | $1,252,576.00 | 1,252,576 |
|
-
VERACYTE, INC.
|
2.39% | $1,251,817.08 | 34,212 |
|
-
ELI LILLY & Co
|
2.34% | $1,225,568.35 | 1,165 |
|
-
Twist Bioscience Corp
|
2.30% | $1,202,888.04 | 25,637 |
|
-
GILEAD SCIENCES, INC.
|
2.28% | $1,192,940.55 | 8,009 |
|
-
ASTRAZENECA PLC
|
2.28% | $1,192,291.64 | 5,706 |
|
-
Beam Therapeutics Inc.
|
2.21% | $1,156,244.42 | 40,627 |
|
-
10x Genomics, Inc.
|
2.16% | $1,132,308.20 | 49,124 |
|
-
Legend Biotech Corp
|
2.14% | $1,122,349.00 | 59,071 |
|
-
Ultragenyx Pharmaceutical Inc.
|
1.78% | $930,430.81 | 39,779 |
|
-
GeneDx Holdings Corp.
|
1.72% | $898,331.70 | 11,270 |
|
-
Wave Life Sciences, Inc.
|
1.50% | $786,278.85 | 56,445 |
|
-
APPLIED MATERIALS INC /DE
|
1.45% | $761,565.67 | 498,918 |
|
-
Sarepta Therapeutics, Inc.
|
1.31% | $686,757.76 | 40,976 |
|
-
Intellia Therapeutics, Inc.
|
1.19% | $621,050.82 | 45,069 |
|
-
CareDx, Inc.
|
0.80% | $418,498.08 | 22,308 |
|
-
uniQure N.V.
|
0.72% | $378,902.46 | 24,242 |
|
-
Vir Biotechnology, Inc.
|
0.70% | $364,854.42 | 40,138 |
|
-
Personalis, Inc.
|
0.41% | $213,471.72 | 23,562 |
|
-
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
|
0.38% | $200,753.28 | 119,496 |
|
-
AGILENT TECHNOLOGIES, INC.
|
0.38% | $200,641.14 | 1,653 |
|
-
ROCKET PHARMACEUTICALS, INC.
|
0.36% | $188,210.67 | 37,567 |
|
-
Prime Medicine, Inc.
|
0.36% | $187,900.02 | 40,671 |
|
-
REGENXBIO Inc.
|
0.35% | $185,166.32 | 20,483 |
|
-
MYRIAD GENETICS INC
|
0.35% | $180,905.62 | 39,242 |
|
-
MESA LABORATORIES INC /CO/
|
0.34% | $178,751.07 | 1,851 |
|
-
MARAVAI LIFESCIENCES HOLDINGS, INC.
|
0.32% | $166,159.44 | 46,674 |
|
-
Stoke Therapeutics, Inc.
|
0.31% | $164,646.02 | 4,522 |
|
-
STANDARD BIOTOOLS INC.
|
0.26% | $134,834.99 | 119,323 |
|
-
Fulgent Genetics, Inc.
|
0.26% | $134,336.79 | 8,763 |
|
-
Arcturus Therapeutics Holdings Inc.
|
0.24% | $123,779.20 | 15,040 |
|
-
Caribou Biosciences, Inc.
|
0.22% | $113,834.70 | 59,913 |
|
-
Sana Biotechnology, Inc.
|
0.21% | $111,316.61 | 26,441 |
|
-
SANGAMO THERAPEUTICS, INC
|
0.20% | $105,835.69 | 244,820 |
|
-
Editas Medicine, Inc.
|
0.20% | $102,759.80 | 46,709 |
Advertisement (320x50)